Browsing Tag
Edwards Lifesciences Corporation
3 posts
egnite and Pathway Labs launch ECG AI pilot at Stamford Health, but can early detection improve patient care?
egnite and Pathway Labs are combining FDA-cleared electrocardiogram artificial intelligence with clinical care coordination at Stamford Health, testing whether earlier identification of structural heart disease can translate into completed diagnostic evaluations and timely treatment decisions.
October 30, 2026
US FTC blocks Edwards Lifesciences acquisition of JenaValve in decisive antitrust win for medical device competition
FTC blocks Edwards Lifesciences Corporation’s JenaValve deal, reshaping medtech M&A and signaling tougher scrutiny of innovation driven acquisitions. Read more.
January 10, 2026
FTC challenges Edwards Lifesciences’ bid for JenaValve over heart-valve competition
Learn why the FTC is suing to block Edwards Lifesciences’ acquisition of JenaValve and what the case means for heart-device innovation and competition.
August 12, 2025